Designed protein handles reveal receptor states without a signalling partner
Rigid protein markers helped image small cell-surface receptors using cryogenic electron microscopy. The peer-reviewed experimental study resolved selected designs for four receptors and examined beta2 adrenergic receptor states without a bound G protein. Some predicted structures missed measured changes. The technique opens a view of receptor behaviour, while possible effects of the attached marker remain unresolved.
Science··Midday
A rigid handle makes small receptors visible
Small membrane receptors are difficult targets for cryogenic electron microscopy, which reconstructs molecular shapes from frozen samples. A peer-reviewed experimental study attached designed protein markers to G protein-coupled receptors, a family that relays signals across cell membranes. The rigid additions supplied a handle for aligning images. For each of four receptors, researchers screened several constructs and imaged the best-behaved candidate; those selected samples all yielded maps at 3.4 angstrom resolution or better.[1]
Leaving the signalling side accessible
An external marker on the beta2 adrenergic receptor left its intracellular side available for examination without a bound G protein. Different bound molecules produced distinct receptor states. A potent activating molecule moved key ordered regions close to the shape seen with the G protein attached, while flexible internal loops showed additional variation. This gives structural evidence about activation before partner binding, rather than requiring the partner itself to hold the receptor in view.[1]
Measured structures expose prediction gaps
Some computational models placed bound molecules incorrectly or missed the receptor changes observed in the microscope. The measurements therefore offer a check on predictions of how a receptor and a molecule fit together. They also have their own limits: the marker adopted an alternative orientation in detergent, freezing may select only part of the available states, and effects of the marker on receptor behaviour cannot yet be excluded. The work tests an imaging method and molecular mechanism, without measuring a treatment outcome.[1]